Skip to main content
NIH funding notice PAR-18-878

Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)

Closed on January 7, 2022.

Posted
July 26, 2018
Close date
January 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $64,297,415 in first-year total cost, median $7,399,274.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BBBP-B (55)]3
  2. Special Emphasis Panel[ZRG1 BBBP-H (55)]2
  3. Special Emphasis Panel[ZAG1 ZIJ-G (M2)]1
  4. Special Emphasis Panel[ZRG1-BBBP-H(55)R]1

Most frequent institutions

  1. ALZHEON, INC.1
  2. BRIGHAM AND WOMEN'S HOSPITAL1
  3. JOHNS HOPKINS UNIVERSITY1
  4. UNIVERSITY OF SOUTH FLORIDA1
  5. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under PAR-18-878 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease1R01AG076634-01FELDMAN, HOWARDGIBSON, GARY ELUCHSINGER, JOSE ALEJANDROWINIFRED MASTERSON BURKE MED RES INST, NY$9,664,204ZRG1
2022Long-Term Nicotine Treatment of Mild Cognitive Impairment2R56AG047992-07A1AISEN, PAUL S.NEWHOUSE, PAUL A.VANDERBILT UNIVERSITY MEDICAL CENTER, TN$6,088,879ZRG1
2022Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study1R01AG076518-01CORESH, JOSEFLIN, FRANK RJOHNS HOPKINS UNIVERSITY, MD$4,123,874ZRG1
2021Cognitive training to reduce incidence of cognitive impairment in older adults1R01AG070349-01EDWARDS, JERRIUNIVERSITY OF SOUTH FLORIDA, FL$7,399,274ZRG1
2020Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study1R01AG065253-01A1ABUSHAKRA, SUSANALZHEON, INC., MA$15,000,000ZRG1
2020DIAN-TU: Tau Next Generation Prevention Trial1R01AG068319-01BATEMAN, RANDALL JWASHINGTON UNIVERSITY, MO$14,973,241ZRG1
2019Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study1R01AG063689-01AISEN, PAUL S.SPERLING, REISA A.BRIGHAM AND WOMEN'S HOSPITAL, MA$7,047,943ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) | ScienceDex | ConductScience